 |
 |
| |
|
|
|
2008 Awards |
|
Shideng Bao, Ph.D.
UCDHSC
Targeting glioma cancer stem cells through CD171 to overcome
radioresistance |
$30,000 |
Donald Bellgrau, Ph.D
UCDHSC
Organ specific targeting of immune responses to tumors |
$30,000 |
Lius Pessoa-Brandao, Ph.D.
UCDHSC
Analysis of MerTK contribution to initiation of leukemogenesis |
$30,000 |
Jeannette E. Davies, Ph.D.
UCDHSC
Decorin regulation of glioma invasion & proteoglycan expression |
$29,760 |
Joaquin M. Espinosa
UC at Boulder
Mechanisms of cell fate choice upon therapeutic
activation of p53 |
$30,000 |
Elan Eisenmesser, Ph.D
UCDHSC
Understanding the dual role in cancer progression of the CD147
cellular receptor |
$30,000 |
Thomas W. Flaig, M.D.
UCDHSC
In vivo validation of DAB389EGF for the treatment of
bladder cancer |
$29,650 |
Barbara A. Frederick, Ph.D.
UCDHSC
Serum Biomarkers to Determine Radiotherapy Response
of Patients with Glioblastoma Multiforme |
$21,000 |
Marileila Varella Garcia, Ph.D.
UCDHSC
Student Cancer Research Fellowship Program |
$30,000 |
Kirk C. Hansen, Ph.D
UCDHSC
Proteomic identification of Tumor-associated Extracellular
Matrix |
$30,000 |
Cheng J. Hu, Ph.D.
UCDHSC
Distinct Role of HIF1a and HIF2a in Tumor Progression |
$30,000 |
Ritsuko Iwanaga, Ph.D
UCDHSC
Role of Six1 in maintaining mammary stem cells |
$30,000 |
Tatiana G. Kutateladze, Ph.D.
UCDHSCStructure and function of CHD4 PHD fingers
|
$30,000 |
Mary Reyland, Ph.D.
UCDHSC
Role of PKCdelta in lymphomagenesis |
$30,000 |
Mara Stewart, Ph.D.
UC at BoulderAn in vivo screen for radiation sensitizers in
Drosophila |
$30,000 |
Jessica Tyler, Ph.D
UCDHSC
Discovering the Mechanistic Basis for the Epigenetic Inheritance
of Transcriptional Activity |
$30,000 |
Michael Wang, M.D.
UCDHSC
Polyoma virus infection and human malignancy |
$30,000 |
Trevor Williams, Ph.D.
UCDHSC
The role of the AP-2 gene family in breast cancer |
$30,000 |
Hang Yin, Ph.D. and Jennifer M. Martin,
Ph.D.
UC at Boulder
Multidisciplinary Approaches to Investigate EBV Activation
(Collaborative Project) |
$59,583 |
Rui Zhao, Ph.D.
UCDHSC
Identify small molecule inhibitors of the Six 1 transcriptional
complexes using high throughput screening |
$30,000 |
|
|
|
|
2007 Awards |
|
Aftab Ahmad, Ph.D.
National Jewish
Mechanisma by shich HIF-2α promotes angiogenesis and
tumorigenesis |
$30,000 |
David Bentley, Ph.D.
UCDHSC
A new chromatin modifying enzyme, the JARID1B lysine demthylase
and its targets in breast cancer cells |
$29,000 |
Dawn Duval, Ph.D.
CSU
Ets Transcription Factors in the Development of Hormone
Refractory Breast Cancer |
$30,000 |
Heide Ford, Ph.D.
UCDHSC
Lymphangiogenesis as a Mechanism of Six1-induced Metastasis
|
$30,000 |
Mark Gregory, Ph.D.
UCDHSC
Targeting Wnt Pathway Components in James DeGregori, Ph.D.
Combinationwith Bcr-Abl Inhibition for the Treatment of
Chronic Myeloid Leukemia |
$29,680 |
Fred Hirsch, Ph.D., M.D.
UCDHSC
Characterization of Molecular Abnormalities of
Insulin-like Growth Factor Signaling Pathway in Lung Cancer |
$28,920 |
Mara Miller, Ph.D.
CSU
Acetylation-dependent trascriptional control by the
HTLV-1-encoded oncoprotien Tax |
$30,000 |
Marileila Varella Garcia, Ph.D.
UCDHSC
Student Cancer Research Fellowship Program |
$25,000 |
|
|
|
2006 Awards |
|
Conrado Stoldt
University of Colorado At Boulder
Molecular Imaging of CA-125 Expression in Ovarian
Carcinoma Cells |
$23,965 |
|
Changwei Liu
UCDHSC
Mechanistic studies of polyubiquitlynation chains in protein
degradation, providing potential therapeutic strategies
for multiple cancers |
$30,000 |
|
Mair E. A. Churchill
UCDHSC
Defining the role of the C-terminus of the Histone
Chaperone ASF-1 in Chromatin Assembly |
$29,696 |
|
Richard F.
Bakemeier
UCDHSC
Student Cancer Research Fellowship Program |
$22,000 |
|
Lynn E. Heasley
UCDHSC
FGF Auatocrine Signalling in Gefitinib- Resistant NSCLC |
$30,000 |
|
Kelly Sawczyn
UCDHSC
Mer Expression in E2A-PBX1 Expressing B-cell Acute Lymphoblastic
Leukemia |
$30,000 |
|
Dylan Taatjes
University of Colorado At Boulder
Function of TRRAP/GCN5 in regulating the p53 tumor suppressor |
$30,000 |
|
Rui Zhao
UCDHSC
Targeting the two-component system to control bacterial
infection in cancer patients |
$10,000 |
|
William P.
Schiemann
National Jewish Medical & Research Center
Mechanisms by which MAGP-2 promotes angiogenesis and
tumorigenesis |
$30,000 |
|
Steven Dow
CSU
Role of Phosphatidylsserine Expression in Regulation MCP-1and
VEGF Production by Tumor Cells and Tumor Associated Macrophages |
$30,000 |
|
Douglas H. Thamm
CSU Animal Cancer Center
Mesenchymal Stem Cells for Cancer Gene Delivery: Pilot Study in
Canine Lung Tumors |
$29,890
|
Linda F. van Dyk
UCDHSC
Molecular regulation of a viral cyclin required for
gammaherpesvirus tumorigenesis |
$30,000 |
|
Glen J. Weiss
UCDHSC
Advance Brochioloalveolar Carcinoma of the Lung: Clinical
Parameters and Gene Expression Signatures that may ID patients
for lung Transplantation |
$29,000 |
|
Brian Parr
UCDHSC
Analysis of erbin as a potential tumor suppressor gene |
$30,000 |
|
|
|
|
2005 Awards |
|
Bruce
Banfield, Ph.D., UCDHSC
Targeting Herpesvirus Infection to B-cell Lymphoma |
$30,000 |
Laurent Gapin, Ph.D., UCDHSC
The
role of T-bet in developing lymphocytes |
$30,000 |
Lia Gore, M.D. and Deborah DeRyckere, Ph.D. UCDHSC
Pre-clinical Characterization of Histone DeacetylaseInhibitor
Anti-tumor Activity Using In Vitro and in Vivo Models of
Pediatric Acute Lymphoblastic Leukemia |
$26,500
|
Douglas
K. Graham, M.D., Ph.D., UCDHSC
Ther Mer tyrosine kinase as a potential therapeutic target in
lymphoblastic leukemias |
$30,000 |
Paul Laybourn, CSU
Mechanism of Histone Gene Expression by HTLV-I Tax |
$29,878 |
Christopher Porter, M.D.
and James DeGregori, Ph.D, UCDHSC
Modeling therapy related acute myelogenous leukemia |
$29,132
|
Yosef
Refaeli, Ph.D.
National Jewish Medical and Research Center
Contributions of IKKgamma (NEMO) in the Ligand-independent
component of BCR signals in homeostasis and neoplasia |
$30,000 |
Jennifer Richer, Ph.D, UCDHSC
The
Role of SDF-1 in Estrogen-dependent Breast Cancer Growth |
$30,000 |
John M. Routes, M.D.,
National Jewish Medical and Research Center
Induction of Tumor Specific Immunity Using E1A |
$30,000 |
K. S.
Shailaja, M.D.
and Pepper Schedin, Ph.D, UCDHSC
Identification of the extra cellular matrix proteome responsible
for breast cancer metastasis |
$26,500 |
Jill E.
Slansky, Ph.D, UCDHSC
Consequences of a hypoxic environment on tumors infiltrating
lymphocytes |
$30,000 |
Raul M.
Torres, UCDHSC
Lsc Regulation of cell adhesion in tumor metastasis |
$26,500 |
Rui Zhao, UCDHSC
Structure-Function Analyses of the Six1 Transcriptional Complex
in Breast Cancer
|
$30,000 |
|
2004 Awards: |
|
Jeffrey S.
Kieft, Ph.D. UCHSC
RNA structure-dependent regulation of a virus associated with
Liver Cancer. |
$15,810 |
William P. Schiemann, Ph.D. National Jewish Medical Center
Use
of Cystatin C to Combat Mammary Tumorigenesis Stimulated by TGF-B |
$30,000 |
Sun-Young Han, Ph.D,
UCHSC
Role of
JNK MAPKs in Mouse Lung Tumorigenesis |
$30,000 |
Roberta Pelanda, Ph.D,
National Jewish Medical Center
Molecular
mechanisms of leukemogenesis |
$30,000 |
Kian Behbakht, M.D, UCHSC
Homeobox gene SIX1 over-expression and modulation of Cellular
Retinoic Acid Binding Protein-II(CRABP-II) in Ovarian Cancer |
$30,000 |
Brooks M. Hybertson, Ph.D. Webb-Waring Institute, UCHSC
Beneficial effects of inhaled tocopheryl succinate aerosols in
Lung Cancer |
$30,000 |
Dahai Gai, Ph.D, UCHSC
Study of the Structure-Function Relationship of Simian Virus 40
(SV40) Large Tumor antigen |
$30,000 |
Carla Van
Den Berg, Pharm.D,
UCHSC
Characterization of caspase-9 resistance in Breast Cancer Cells |
$30,000 |
Britta M. Jacobsen, Ph.D, UCHSC
Role of Progesterone Receptor Ratio in Breast Cancer Cells |
$30,000 |
Samir Witta, M.D. UCHSC
Improvement of Response to EGFR Inhibitors in Non-small Cell
Lung Cancer |
$30,000 |
Tatiana G. Kutateladze, Ph.D, UCHSC
Structural basis of signaling by RUFY1 |
$30,000 |
Diego A.R. Zorio, Ph.D, UCHSC
A
novel way of generating gene expression profiles in cancer cells
|
$30,000 |
|
2003 Awards: |
|
|
Virginia
F.
Borges,
M.D.
Ass’t Professor of Medicine UCHSC
Stimulation of immune response on human breast cancer by a novel
vaccine-a pilot study. |
$27,470 |
G.S. Capelluto, Ph.D.
Pharmacology UCHSC
Defining the Molecular basis of Prickle interactions in the Wnt
signaling pathway. |
$29,500 |
|
Richard
Coletta, D.D.S. Fellow, UCHSC
Heide Ford, Ph.D. UCHSC
The effect of Breast Cancer associated w/six 1 homebox gene on
cellar proliferation via induction of cyclin A 1 |
$28,777 |
|
Arthur
Gutierrez-Hartman, Director Medical Scientist Training Program,
Professor
Biological function of ETS transcription factors in mammalian lung
tumorigeneis |
$19,000 |
|
Jian Huang, Fellow, UCHSC Trevor William, Associate Professor,
Mentor UCHSC
The role of AP-2 Beta Breast Cancer |
$30,000 |
|
Joseph J. Lucas, Ph.D., Staff Scientist/Assoc. Professor National
Jewish Medical & Research Center
Function of p57KIP2, a protein deficient in T and B cell cancers |
$30,000 |
|
Jennifer Richer, M.D, Ass’t Professor Div. of Endocrinology
Role of ZEB 1 in Normal Mammary Gland Development & Breast Cancer |
$30,000 |
|
Robert Sclafani, Ph.D, Professor, UCHSC
Mechanism of Tobacco-Induced Mutagenesis in Oral Cancers |
$30,000 |
|
Juan Sun
M.D. Post Doctoral Fellow
AMC Research Center
Jaimie Modiano V.M.D.,
Ph.D. Scientist
Center for Cancer Causation and Prevention
Fas ligand based gene therapy |
$30,104 |
Angela
Trobaugh-Lotraio
Pediatric Hematology/Oncology
Fellow Physician, UCHSC & The Children’s Hospital
James
Degregori,
Assistant Professor, UCHSC
The
Role of decreased ASFL-B expression in abnormal S phase
progression, altered hematopoiesis and increased tumorigenesis in
E2F1/E2F2-mutant mice.
|
$30,000 |
2002 Awards: |
|
Michele Basche, M.D. UCHSC
An age-stratified phase I clinical trial of the combination
capecitabinem, ZD 1839, and oxaliplatin in patients with advanced
solid tumors |
$29,960. |
Neehar Bhatia, Ph.D. AMC
Analysis for Beta-catenin/Tcf Signaling in Skin Carcinogenesis |
$23,682. |
Andrew P. Bradford, Ph.D. and
Twila Jackson, Ph.D. UCHSC
FGF Regulation of Cell Proliferation in Pituitary Cancer:
Role of Id2 |
$23,682. |
Lin Qi, Ph.D. UCHSC
EGF-PAP Fusion Protein to Target Prostate Cancer |
$29,560. |
Peter McSweeney, M.D.
UCHSC
Vaccination with Mutated VHL Genes as a Treatment for Renal Cell
Carcinoma |
$28,060. |
John Routes, M.D. and Tanya
Miura, Ph.D., M.D. NJMRC
The Role of Lipid Rafts in Signaling by TNF-related
Apoptosis-inducing Ligand |
$30,000. |
Jill Slansky, Ph.D. UCHSC
Binding Properties of T cells Responding to Tumors |
$30,000. |
Harriet Watkin, Ph.D.
UCHSC
Mammary Gland Development & Signaling in Mice lacking Akt1 |
$20,055. |
2001 Awards: |
|
Thomas E. Allen, Ph.D. CSU
Investigation of the Pathogenesis of a Retrovirus
Induced Lung Cancer in a Transgenic Mouse |
$30,102. |
Anne Brauweiler, Ph.D. and John
C. Cambier, Ph.D. National Jewish The Role of
Interferon-Gamma in
Macrophage Meditated ADCC |
$30,000. |
Dawn R. Clark, Ph.D.
National Jewish
B and NK Cell Lineage Decisions |
$30,000. |
Bruce D. Cuevas, Ph.D.
UCHSC
Induced Breast Tumorigenesis and Metastasis
Defining the Role of MEKK1 in Oncogene |
$30,000. |
Zonghan Dai, Ph.D. UCHSC
The Role Rac Signal Transduction in Bcr-Abl-Induced Leukemogenesis
|
$30,000. |
S. Gail Eckhardt, M.D.
UCHSC
Correlative and Biological Studies of the Integrin Antagonist, EMD
121974 |
$31,280. |
Gongyi, Zhang, Ph.D.
National Jewish
Domain characterization and Crystallization of Polo-Box
Domain, Kinase Domain and Entire Kinase of P1x1 |
$30,000. |
Daniel L. Gustafson, Ph.D.
UCHSC
Antiangiogenic Scheduling of CPT-11 |
$29,890. |
William P. Schiemann, Ph.D.
National Jewish
Induction of SPARC by TGF-Beta: Effects on Tumor Growth
and Metastasis |
$30,000. |
|
Julie
Flieitz, M.D. and Robert Garcea, M.D. UCHSC and
The Childrens Hospital
Prospective Study of the Association Between Polyomaviruses
(JCV, BKVmSV40) and Pediatric Neuroblastomas and Brain Tumors
|
$29,966. |
|
|
|
|
|
|
